Mounjaro generic availability, cost, and more

In this article:

• Generic Mounjaro
• When will it be available?
• Generic vs. brand-name
• Is Mounjaro covered by insurance?
• How to get coverage
• Alternatives
• How to save
• Expert takeaway

In this article

• Generic Mounjaro
• When will it be available?
• Generic vs. brand-name
• Is Mounjaro covered by insurance?
• How to get coverage
• Alternatives
• How to save
• Expert takeaway

Mounjaro is an FDA-approved medication for Type 2 diabetes in adults and children over 10. It helps manage blood sugar levels as a dual GIP and GLP-1 agonist. There is no generic version of Mounjaro currently available, and one might not be available until at least the early 2030s. The manufacturer, Eli Lilly, currently holds patent rights that prevent other companies from making a generic. Still, using savings options like discount cards or trying a different medication may help with managing costs.

Mounjaro generic availability
Generic name	Tirzepatide
Is there a generic available for sale in the U.S.?	No
When will a generic be available?	Early 2030s (tentative and based on FDA approval)

Is there a generic for Mounjaro?

No, there is no generic approved drug of Mounjaro. 

“Mounjaro is relatively new, and I don’t expect an FDA approval for the generic version anytime soon,” says Mir Ali, MD, a bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, California.

Mounjaro is much newer than Victoza or Byetta, the GLP-1s that are now available in generic form. Dr. Ali says both those drugs have been around for at least 12 years longer than Mounjaro, which was approved for diabetes management in 2022 (it is still not FDA-approved for obesity or weight management). Zepbound, another drug with the active ingredient tirzepatide, is approved for weight loss, but there is no generic for Zepbound either. There are also no generic alternatives for the GLP-1s Ozempic (semaglutide), Wegovy (semaglutide), or Trulicity (dulaglutide). 

When will a generic Mounjaro be available?

Generic versions of medications become available only after the brand-name drug’s patent and exclusivity rights expire. In the case of Mounjaro, the pharmaceutical company Eli Lilly holds a patent for both the medication and its injection delivery device. 

To be approved, a generic drug needs to be bioequivalent to the brand-name product and work the same way. That means it needs to contain the same active ingredient, strength, dosage form, and route of administration. However, a generic manufacturer can’t submit an application until patent protections expire.

“In the United States, brand-name drugs are protected by patents for about 20 years, but companies often extend that through additional patents and exclusivity agreements,” explains Marlee Bruno, a certified physician’s assistant and the founder of Mind Body & Soul Medical in Pensacola, Florida. “A generic version [of Mounjaro] likely won’t be available until at least the early 2030s.”

While it’s not possible to predict exactly when a generic Mounjaro will be available, it’s safe to say that it will take several more years.

What are the differences between generic vs. brand-name Mounjaro?

Although there are no generic versions of Mounjaro, compounded tirzepatide is often suggested as an alternative. Compounded tirzepatide is a custom-mixed version of Mounjaro’s active ingredient. As a brand-name drug, Mounjaro can cost more than $1,400 per month without insurance. Compounded tirzepatide may be available at a lower price, but insurance companies generally don’t cover it since it’s not FDA-approved.

“A lot of people assume compounded tirzepatide is just a cheaper, generic version of Mounjaro. It’s not,” emphasizes Bruno. 

So, why is compounded tirzepatide even available? The answer has to do with supply and demand. Pharmacies were allowed to start selling compounded tirzepatide because of a Mounjaro shortage. But in December 2024, the FDA announced that the tirzepatide shortage had ended. Compounded versions are now facing more scrutiny from the FDA.

Is Mounjaro covered by insurance?

Insurance coverage for Mounjaro will depend on the plan. In many cases, Mounjaro may be covered by commercial insurance plans when it’s prescribed for Type 2 diabetes. Some Medicare and Medicaid plans may also cover diabetes medications like Mounjaro.

Still, patients may have to pay out-of-pocket costs, such as copays or coinsurance, even with insurance coverage. Out-of-pocket costs can also depend on whether deductibles have been met.

All things considered, the cost of Mounjaro with insurance can still be high for some people. That’s why the manufacturer offers a savings card for those with commercial insurance that can help reduce costs. In addition, prescription savings cards like the one from SingleCare may help reduce the retail price of Mounjaro. 

How do you get Mounjaro covered by insurance?

If Mounjaro isn’t covered by insurance, you can contact your insurance provider for the exact reason. Oftentimes, they require prior authorization, meaning your healthcare provider must submit documentation explaining why Mounjaro is medically necessary. They may have to provide evidence of your medical history and overall condition.

Many insurance plans also require step therapy, since Mounjaro may not be a preferred drug on their formulary. With step therapy, you’ll have to try lower-cost alternatives to Mounjaro before your insurance plan will cover it. If coverage is still denied, you can always file an appeal with help from your healthcare provider.

Generic alternatives to Mounjaro

Mounjaro isn’t the only option for treating Type 2 diabetes. Although it’s effective, there are other medications that can act as alternatives and that may have lower-cost generic forms available.

Alternatives to Mounjaro include:

• Other GLP-1 agonists, such as Ozempic (semaglutide), Wegovy (semaglutide), Rybelsus (semaglutide), Trulicity (dulaglutide), Victoza (liraglutide), and Saxenda (liraglutide)
• DPP-4 Inhibitors, such as Januvia (sitagliptin), Onglyza (saxagliptin), and Tradjenta (linagliptin)
• SGLT2 Inhibitors, such as Invokana (canagliflozin) and Jardiance (empagliflozin)
• Biguanides, such as Glucophage (metformin)
• Sulfonylureas, such as Glucotrol (glipizide), Diabeta (glyburide), and Amaryl (glimepiride)
• Thiazolidinediones, such as Actos (pioglitazone) and Avandia (rosiglitazone)

Generic versions of these drugs could help save on costs. Metformin is widely available as a generic and is often prescribed as a first-line treatment for Type 2 diabetes. Among the GLP-1 agonists, liraglutide is now available as a generic, but it’s taken once daily instead of once weekly. Saxagliptin, a DPP-4 inhibitor, is also available in generic form.

Always consult a healthcare provider before considering a medication switch. They can help determine the best treatment option for your condition.

How to save on Mounjaro

There are ways to save on Mounjaro until a more affordable generic version becomes available. For instance, Bruno suggests looking into the income requirements for Eli Lilly’s patient assistance program. Changing insurance plans might also lower a person’s out-of-pocket costs. 

In addition, it’s possible to use HSA or FSA funds to reduce out-of-pocket costs. Comparing prices at different pharmacies may be helpful since retail costs can vary by location. Cash payers can also save on Mounjaro with coupons from SingleCare, which could lower the cost from $1,530 to $895 for a four-week supply.

Free coupons for more weight loss drugs

Expert takeaway 

The landscape for GLP-1 coverage and costs is changing, with many insurance plans expanding coverage for medications like Mounjaro. Although a generic Mounjaro is not yet available, there are many ways to potentially save on treatment costs.

The SingleCare prices in this article are the most accurate at the time of publishing in ZIP code 23666 as of 3/5/26. Prices vary by pharmacy. Visit our Mounjaro coupon page for updated Mounjaro prices near you.